These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1332464)

  • 1. Elucidating the clandestine behavior of enantiomeric DHPs in calcium channels.
    Smith N; Sun H
    J Gen Physiol; 2023 Nov; 155(11):. PubMed ID: 37830978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydropyridine calcium channel blockers and renal disease.
    Robles NR; Fici F; Grassi G
    Hypertens Res; 2017 Jan; 40(1):21-28. PubMed ID: 27412800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of calcium channel blockers on the outcome of acute myeloid leukemia.
    Chae YK; Dimou A; Pierce S; Kantarjian H; Andreeff M
    Leuk Lymphoma; 2014 Dec; 55(12):2822-9. PubMed ID: 24628293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for hepatitis C virus-induced portal hypertension in leukemic children.
    El-Ashry R; Malek HA; Ghayaty EA; El-Gendy AA; Darwish A; Al-Tonbary Y
    Med Oncol; 2013; 30(2):559. PubMed ID: 23553276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
    Kumar S; Hall RJ
    Drugs Aging; 2003; 20(11):805-15. PubMed ID: 12964887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2+ channel blockers.
    Wenzel U; Kuntz S; Diestel S; Daniel H
    Antimicrob Agents Chemother; 2002 May; 46(5):1375-80. PubMed ID: 11959571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual mode of action of dihydropyridine calcium antagonists: a role for nitric oxide.
    Dhein S; Salameh A; Berkels R; Klaus W
    Drugs; 1999 Sep; 58(3):397-404. PubMed ID: 10493269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular aspects of calcium channel antagonism.
    Schwartz A
    Am J Cardiol; 1992 Nov; 70(16):6F-8F. PubMed ID: 1332464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.
    Okuyama R; Adachi-Akahane S; Nagao T
    Br J Pharmacol; 1994 Oct; 113(2):451-6. PubMed ID: 7834195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for calcium antagonists.
    Schwartz A; McKenna E; Vaghy PL
    Am J Cardiol; 1988 Oct; 62(11):3G-6G. PubMed ID: 2845766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.